Industry and policy makers should work together to find ways to improve access to life saving vaccines DCVMN says
Industry and policy makers should work together to find ways to improve access to life saving vaccines DCVMN says • [...]
GVK Biosciences Opens New Clinical Pharmacology Unit in Ahmedabad
GVK Biosciences Opens New Clinical Pharmacology Unit in Ahmedabad New Facility Commissioned to Meet Increasing Business Demand Hyderabad, India, March [...]
Veeda announces the appointment of Mr. Venu Madhav as the new COO
Veeda Clinical Research announced the appointment of Mr. Venu Madhav as the new Chief Operating Officer of its unit in [...]
Bharat Bio Vaccine Doses Touch 1 Billion
Bharat Biotech is a global manufacturer of vaccines to protect against rabies, polio, hepatitis-B, typhoid, diphtheria, pertussius, tetanus, haemophilus influenza [...]
Jubilant Q3 results : Jubilant Organosys to further sharpen its focus on Pharma & Life Sciences business by demerging its Agri and Performance Polymer business
Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India, today [...]
Taro Shareholders to Levitt and Directors: Quit the Board
Taro Shareholders to Levitt and Directors: Quit the Board Minority Shareholders also Reject Indemnification Proposals Mumbai, Maharashtra, India, Thursday, December [...]
Riester Ri-Vital Spot-Check Monitor Measures Vital Signs in Seconds
Riester Ri-Vital Spot-Check Monitor Measures Vital Signs in Seconds Mumbai, Maharashtra, India, Monday, December 28, 2009 / IndiaPRLine / — [...]
Ocimum Biosolutions is India’s 4th fastest growing Technology Company
Ocimum Biosolutions is India’s 4th fastest growing Technology Company Ranked 42 on Deloitte Technology Fast 500 Asia Pacific 2009 Program [...]
Novavax Announces Release Date of 2009 Third Quarter, Financial Results and Investor Conference Call
ROCKVILLE, MD, (Oct 30, 2009) /IndiaPRLine.com/ – Novavax, Inc. (Nasdaq: NVAX) today announced that it will report its 2009 third [...]
Biocon Limited Announces Results for the Half-Year Ended September 30, 2009
Revenues rise to Rs 1,098 crores; EBITDA at Rs 236 crores; PAT at Rs 132 crores. “Our numbers tell our [...]